1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Healthcare-Acquired Infection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Pharmaceutical Treatment 1.2.3 Environment Treatment 1.2.4 Medical Devices Management 1.3 Market by Application 1.3.1 Global Healthcare-Acquired Infection Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Ambulatory Surgery Centers 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Healthcare-Acquired Infection Market Perspective (2016-2027) 2.2 Healthcare-Acquired Infection Growth Trends by Regions 2.2.1 Healthcare-Acquired Infection Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Healthcare-Acquired Infection Historic Market Share by Regions (2016-2021) 2.2.3 Healthcare-Acquired Infection Forecasted Market Size by Regions (2022-2027) 2.3 Healthcare-Acquired Infection Industry Dynamic 2.3.1 Healthcare-Acquired Infection Market Trends 2.3.2 Healthcare-Acquired Infection Market Drivers 2.3.3 Healthcare-Acquired Infection Market Challenges 2.3.4 Healthcare-Acquired Infection Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Healthcare-Acquired Infection Players by Revenue 3.1.1 Global Top Healthcare-Acquired Infection Players by Revenue (2016-2021) 3.1.2 Global Healthcare-Acquired Infection Revenue Market Share by Players (2016-2021) 3.2 Global Healthcare-Acquired Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Healthcare-Acquired Infection Revenue 3.4 Global Healthcare-Acquired Infection Market Concentration Ratio 3.4.1 Global Healthcare-Acquired Infection Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Healthcare-Acquired Infection Revenue in 2020 3.5 Healthcare-Acquired Infection Key Players Head office and Area Served 3.6 Key Players Healthcare-Acquired Infection Product Solution and Service 3.7 Date of Enter into Healthcare-Acquired Infection Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Healthcare-Acquired Infection Breakdown Data by Type 4.1 Global Healthcare-Acquired Infection Historic Market Size by Type (2016-2021) 4.2 Global Healthcare-Acquired Infection Forecasted Market Size by Type (2022-2027) 5 Healthcare-Acquired Infection Breakdown Data by Application 5.1 Global Healthcare-Acquired Infection Historic Market Size by Application (2016-2021) 5.2 Global Healthcare-Acquired Infection Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Healthcare-Acquired Infection Market Size (2016-2027) 6.2 North America Healthcare-Acquired Infection Market Size by Type 6.2.1 North America Healthcare-Acquired Infection Market Size by Type (2016-2021) 6.2.2 North America Healthcare-Acquired Infection Market Size by Type (2022-2027) 6.2.3 North America Healthcare-Acquired Infection Market Size by Type (2016-2027) 6.3 North America Healthcare-Acquired Infection Market Size by Application 6.3.1 North America Healthcare-Acquired Infection Market Size by Application (2016-2021) 6.3.2 North America Healthcare-Acquired Infection Market Size by Application (2022-2027) 6.3.3 North America Healthcare-Acquired Infection Market Size by Application (2016-2027) 6.4 North America Healthcare-Acquired Infection Market Size by Country 6.4.1 North America Healthcare-Acquired Infection Market Size by Country (2016-2021) 6.4.2 North America Healthcare-Acquired Infection Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Healthcare-Acquired Infection Market Size (2016-2027) 7.2 Europe Healthcare-Acquired Infection Market Size by Type 7.2.1 Europe Healthcare-Acquired Infection Market Size by Type (2016-2021) 7.2.2 Europe Healthcare-Acquired Infection Market Size by Type (2022-2027) 7.2.3 Europe Healthcare-Acquired Infection Market Size by Type (2016-2027) 7.3 Europe Healthcare-Acquired Infection Market Size by Application 7.3.1 Europe Healthcare-Acquired Infection Market Size by Application (2016-2021) 7.3.2 Europe Healthcare-Acquired Infection Market Size by Application (2022-2027) 7.3.3 Europe Healthcare-Acquired Infection Market Size by Application (2016-2027) 7.4 Europe Healthcare-Acquired Infection Market Size by Country 7.4.1 Europe Healthcare-Acquired Infection Market Size by Country (2016-2021) 7.4.2 Europe Healthcare-Acquired Infection Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Healthcare-Acquired Infection Market Size (2016-2027) 8.2 Asia-Pacific Healthcare-Acquired Infection Market Size by Type 8.2.1 Asia-Pacific Healthcare-Acquired Infection Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Healthcare-Acquired Infection Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Healthcare-Acquired Infection Market Size by Type (2016-2027) 8.3 Asia-Pacific Healthcare-Acquired Infection Market Size by Application 8.3.1 Asia-Pacific Healthcare-Acquired Infection Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Healthcare-Acquired Infection Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Healthcare-Acquired Infection Market Size by Application (2016-2027) 8.4 Asia-Pacific Healthcare-Acquired Infection Market Size by Region 8.4.1 Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Healthcare-Acquired Infection Market Size (2016-2027) 9.2 Latin America Healthcare-Acquired Infection Market Size by Type 9.2.1 Latin America Healthcare-Acquired Infection Market Size by Type (2016-2021) 9.2.2 Latin America Healthcare-Acquired Infection Market Size by Type (2022-2027) 9.2.3 Latin America Healthcare-Acquired Infection Market Size by Type (2016-2027) 9.3 Latin America Healthcare-Acquired Infection Market Size by Application 9.3.1 Latin America Healthcare-Acquired Infection Market Size by Application (2016-2021) 9.3.2 Latin America Healthcare-Acquired Infection Market Size by Application (2022-2027) 9.3.3 Latin America Healthcare-Acquired Infection Market Size by Application (2016-2027) 9.4 Latin America Healthcare-Acquired Infection Market Size by Country 9.4.1 Latin America Healthcare-Acquired Infection Market Size by Country (2016-2021) 9.4.2 Latin America Healthcare-Acquired Infection Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Healthcare-Acquired Infection Market Size (2016-2027) 10.2 Middle East & Africa Healthcare-Acquired Infection Market Size by Type 10.2.1 Middle East & Africa Healthcare-Acquired Infection Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Healthcare-Acquired Infection Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Healthcare-Acquired Infection Market Size by Type (2016-2027) 10.3 Middle East & Africa Healthcare-Acquired Infection Market Size by Application 10.3.1 Middle East & Africa Healthcare-Acquired Infection Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Healthcare-Acquired Infection Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Healthcare-Acquired Infection Market Size by Application (2016-2027) 10.4 Middle East & Africa Healthcare-Acquired Infection Market Size by Country 10.4.1 Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Healthcare-Acquired Infection Introduction 11.1.4 Pfizer Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Healthcare-Acquired Infection Introduction 11.2.4 Novartis Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche Healthcare-Acquired Infection Introduction 11.3.4 Roche Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.3.5 Roche Recent Development 11.4 Sanofi 11.4.1 Sanofi Company Details 11.4.2 Sanofi Business Overview 11.4.3 Sanofi Healthcare-Acquired Infection Introduction 11.4.4 Sanofi Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.4.5 Sanofi Recent Development 11.5 Abbott 11.5.1 Abbott Company Details 11.5.2 Abbott Business Overview 11.5.3 Abbott Healthcare-Acquired Infection Introduction 11.5.4 Abbott Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.5.5 Abbott Recent Development 11.6 BD 11.6.1 BD Company Details 11.6.2 BD Business Overview 11.6.3 BD Healthcare-Acquired Infection Introduction 11.6.4 BD Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.6.5 BD Recent Development 11.7 Hologic 11.7.1 Hologic Company Details 11.7.2 Hologic Business Overview 11.7.3 Hologic Healthcare-Acquired Infection Introduction 11.7.4 Hologic Revenue in Healthcare-Acquired Infection Business (2016-2021) 11.7.5 Hologic Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Healthcare-Acquired Infection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Pharmaceutical Treatment Table 3. Key Players of Environment Treatment Table 4. Key Players of Medical Devices Management Table 5. Global Healthcare-Acquired Infection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Healthcare-Acquired Infection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Healthcare-Acquired Infection Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Healthcare-Acquired Infection Market Share by Regions (2016-2021) Table 9. Global Healthcare-Acquired Infection Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Healthcare-Acquired Infection Market Share by Regions (2022-2027) Table 11. Healthcare-Acquired Infection Market Trends Table 12. Healthcare-Acquired Infection Market Drivers Table 13. Healthcare-Acquired Infection Market Challenges Table 14. Healthcare-Acquired Infection Market Restraints Table 15. Global Healthcare-Acquired Infection Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Healthcare-Acquired Infection Market Share by Players (2016-2021) Table 17. Global Top Healthcare-Acquired Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-Acquired Infection as of 2020) Table 18. Ranking of Global Top Healthcare-Acquired Infection Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Healthcare-Acquired Infection Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Healthcare-Acquired Infection Product Solution and Service Table 22. Date of Enter into Healthcare-Acquired Infection Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Healthcare-Acquired Infection Market Size by Type (2016-2021) (US$ Million) Table 25. Global Healthcare-Acquired Infection Revenue Market Share by Type (2016-2021) Table 26. Global Healthcare-Acquired Infection Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Healthcare-Acquired Infection Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Healthcare-Acquired Infection Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Healthcare-Acquired Infection Revenue Market Share by Application (2016-2021) Table 30. Global Healthcare-Acquired Infection Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Healthcare-Acquired Infection Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Healthcare-Acquired Infection Market Size by Type (2016-2021) (US$ Million) Table 33. North America Healthcare-Acquired Infection Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Healthcare-Acquired Infection Market Size by Application (2016-2021) (US$ Million) Table 35. North America Healthcare-Acquired Infection Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Healthcare-Acquired Infection Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Healthcare-Acquired Infection Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Healthcare-Acquired Infection Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Healthcare-Acquired Infection Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Healthcare-Acquired Infection Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Healthcare-Acquired Infection Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Healthcare-Acquired Infection Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Healthcare-Acquired Infection Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Healthcare-Acquired Infection Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Healthcare-Acquired Infection Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Healthcare-Acquired Infection Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Healthcare-Acquired Infection Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Healthcare-Acquired Infection Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Healthcare-Acquired Infection Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Healthcare-Acquired Infection Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Healthcare-Acquired Infection Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Healthcare-Acquired Infection Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Healthcare-Acquired Infection Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Healthcare-Acquired Infection Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Healthcare-Acquired Infection Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Healthcare-Acquired Infection Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Healthcare-Acquired Infection Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Healthcare-Acquired Infection Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Healthcare-Acquired Infection Market Size by Country (2022-2027) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Healthcare-Acquired Infection Product Table 65. Pfizer Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Novartis Company Details Table 68. Novartis Business Overview Table 69. Novartis Healthcare-Acquired Infection Product Table 70. Novartis Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 71. Novartis Recent Development Table 72. Roche Company Details Table 73. Roche Business Overview Table 74. Roche Healthcare-Acquired Infection Product Table 75. Roche Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 76. Roche Recent Development Table 77. Sanofi Company Details Table 78. Sanofi Business Overview Table 79. Sanofi Healthcare-Acquired Infection Product Table 80. Sanofi Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 81. Sanofi Recent Development Table 82. Abbott Company Details Table 83. Abbott Business Overview Table 84. Abbott Healthcare-Acquired Infection Product Table 85. Abbott Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 86. Abbott Recent Development Table 87. BD Company Details Table 88. BD Business Overview Table 89. BD Healthcare-Acquired Infection Product Table 90. BD Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 91. BD Recent Development Table 92. Hologic Company Details Table 93. Hologic Business Overview Table 94. Hologic Healthcare-Acquired Infection Product Table 95. Hologic Revenue in Healthcare-Acquired Infection Business (2016-2021) & (US$ Million) Table 96. Hologic Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Healthcare-Acquired Infection Market Share by Type: 2020 VS 2027 Figure 2. Pharmaceutical Treatment Features Figure 3. Environment Treatment Features Figure 4. Medical Devices Management Features Figure 5. Global Healthcare-Acquired Infection Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinics Case Studies Figure 8. Ambulatory Surgery Centers Case Studies Figure 9. Others Case Studies Figure 10. Healthcare-Acquired Infection Report Years Considered Figure 11. Global Healthcare-Acquired Infection Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Healthcare-Acquired Infection Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Healthcare-Acquired Infection Market Share by Regions: 2020 VS 2027 Figure 14. Global Healthcare-Acquired Infection Market Share by Regions (2022-2027) Figure 15. Global Healthcare-Acquired Infection Market Share by Players in 2020 Figure 16. Global Top Healthcare-Acquired Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-Acquired Infection as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Healthcare-Acquired Infection Revenue in 2020 Figure 18. Global Healthcare-Acquired Infection Revenue Market Share by Type (2016-2021) Figure 19. Global Healthcare-Acquired Infection Revenue Market Share by Type (2022-2027) Figure 20. North America Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Healthcare-Acquired Infection Market Share by Type (2016-2027) Figure 22. North America Healthcare-Acquired Infection Market Share by Application (2016-2027) Figure 23. North America Healthcare-Acquired Infection Market Share by Country (2016-2027) Figure 24. United States Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Healthcare-Acquired Infection Market Share by Type (2016-2027) Figure 28. Europe Healthcare-Acquired Infection Market Share by Application (2016-2027) Figure 29. Europe Healthcare-Acquired Infection Market Share by Country (2016-2027) Figure 30. Germany Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Healthcare-Acquired Infection Market Share by Type (2016-2027) Figure 38. Asia-Pacific Healthcare-Acquired Infection Market Share by Application (2016-2027) Figure 39. Asia-Pacific Healthcare-Acquired Infection Market Share by Region (2016-2027) Figure 40. China Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Healthcare-Acquired Infection Market Share by Type (2016-2027) Figure 48. Latin America Healthcare-Acquired Infection Market Share by Application (2016-2027) Figure 49. Latin America Healthcare-Acquired Infection Market Share by Country (2016-2027) Figure 50. Mexico Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Healthcare-Acquired Infection Market Share by Type (2016-2027) Figure 54. Middle East & Africa Healthcare-Acquired Infection Market Share by Application (2016-2027) Figure 55. Middle East & Africa Healthcare-Acquired Infection Market Share by Country (2016-2027) Figure 56. Turkey Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Healthcare-Acquired Infection Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Pfizer Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 60. Novartis Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 61. Roche Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 62. Sanofi Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 63. Abbott Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 64. BD Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 65. Hologic Revenue Growth Rate in Healthcare-Acquired Infection Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Pfizer Novartis Roche Sanofi Abbott BD Hologic